About Us

FSD Pharma is a specialty biotech pharmaceutical R&D company. FSD Pharma BioSciences, a wholly-owned subsidiary, is focused on developing over time multiple applications of the company’s lead compound FSD201, ultra-micronized palmitoylethanolamide (PEA), by down-regulating the cytokines to effectuate an anti-inflammatory response.

Our Mission

We are a science driven company focused on the research and development of FDA approved pharmaceuticals addressing acute and chronic medical conditions.